Fundz

Kuros Biosciences

Schlieren, Zurich, Switzerland · Biotechnology, Health Care, Manufacturing

Kuros Biosciences is a leader in innovative biologic technologies. The company specializes in developing solutions for minimally invasive surgical procedures, focusing on bone graft delivery systems. Their mission is to empower surgeons with innovative products that enhance surgical outcomes.

Key facts

Headquarters
Schlieren, Zurich, Switzerland
Employees
130
Industries
Biotechnology, Health Care, Manufacturing
Status
Private
Website
kurosbio.com
LinkedIn
Company page

Recent activity at Kuros Biosciences

Leadership

  • John Griffin, Chief Business Officer
  • I.V. Hall, Chief Operating Officer

Verified email and direct lines for Kuros Biosciences’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Kuros Biosciences in the news

Companies similar to Kuros Biosciences

  • Anteris Technologies · Biotechnology, Health Care, Manufacturing, Medical Device, medical devices
  • InspireMD · Biotechnology, Health Care, Manufacturing, Medical Device, medical devices
  • PROTEOR · Biotechnology, Health Care, Manufacturing, Medical Device, medical devices
  • IceCure Medical · Biotechnology, Health Care, Manufacturing, Medical Device, medical devices
  • Cornerstone Robotics · Biotechnology, Health Care, Manufacturing, Medical Device, medical devices

About Kuros Biosciences: questions and answers

What does Kuros Biosciences do?

Kuros Biosciences is a leader in innovative biologic technologies. The company specializes in developing solutions for minimally invasive surgical procedures, focusing on bone graft delivery systems. Their mission is to empower surgeons with innovative products that enhance surgical outcomes.

Where is Kuros Biosciences headquartered?

Kuros Biosciences is headquartered in Schlieren, Zurich, Switzerland.

How many employees does Kuros Biosciences have?

Kuros Biosciences has about 130 employees.

What is the latest news on Kuros Biosciences?

On May 08, 2026, Kuros Biosciences Appoints I.V. Hall as Chief Operating Officer

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Kuros Biosciences across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.